共 123 条
[1]
Jaff MR(2009)Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to “bridge” patients instead of intravenous unfractionated heparin? Catheter Cardiovasc Interv 74 S17-21
[2]
Spyropoulos AC(2006)Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry J Thromb Haemost 4 1246-52
[3]
Turpie AGG(2008)Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry) Am J Cardiol 102 883-9
[4]
Dunn AS(2004)low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin. Assessment of a standardized periprocedural anticoagulation regimen Arch lntern Med 164 1319-26
[5]
Spandorfer J(2004)Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of Warfarin Circulation 110 1658-63
[6]
Douketis J(2008)Venous thromboembolic disease after total hip and knee arthroplasty J Bone Joint Surg Am. 90-A 2764-80
[7]
Jacobson A(2012)Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest physicians. Evidence-based clinical practice guidelines Chest 141 e326s-50
[8]
Frost FJ(2006)International consensus statement Int Angiol 25 101-61
[9]
Spyropoulos AC(2012)American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty J Bone Joint Surg Am 94 746-7
[10]
Turpie AGG(2003)Management of venous thromboembolism. Past, present and future Arch lntern Med 1063 759-68